David Peng, MD
Ann Arbor, MI 48109
Manage Your Profile
About
Dr. Peng serves as the director of pediatric heart failure and mechanical circulatory support at C.S. Mott Children’s Hospital Congenital Heart Center. He specializes in the care of children with heart failure, cardiomyopathy, ventricular assist devices (VADs), and heart transplantation. He holds leadership positions within the Advanced Cardiac Therapies Improving Outcomes Network (ACTION), International Society for Heart and Lung Transplantation, Society of Thoracic Surgeons, and International Pediatric Transplant Association.
Links
twitter
Research Overview
Dr. Peng’s current research interests include pediatric clinical trials, ventricular assist devices, myocardial recovery, novel medical and device therapies for heart failure, and molecular diagnosistics in heart transplantation.
Recent Publications
-
Norman A, Goldberg CS, Crandall B, Plegue M, Duimstra A, Arbit M, Das S, Mekhaldi S, Lim HM, Peng DM, Schumacher K, McCormick AD. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 692Proceeding / Abstract / Poster(1505) Social Drivers of Health and Heart Failure Medication Use in Children with Reduced Ventricular Function
DOI:10.1016/j.healun.2026.02.1519 -
Marshall MK, McCormick AD, Peng DM, Schumacher KR, Mazumder NR, Lim HM. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 699Proceeding / Abstract / Poster(1523) Are We out of the Woods? Hepatocellular Carcinoma After Heart Transplantation for Fontan Circulatory Failure
DOI:10.1016/j.healun.2026.02.1537 -
Mikati HKE, Najor M, Baal P, Duimstra A, Arbit M, Sinicropi N, Giacobbe B, Dudley E, Cusick M, Lim H, Peng D, Schumacher K, McCormick A. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 708 - 709.Proceeding / Abstract / Poster(1545) Early Donor-Specific Antibodies After Heart Transplant in Pediatric Fontan Circulatory Failure: Associations with Rejection and Mortality
DOI:10.1016/j.healun.2026.02.1559 -
Verma SD, Yu S, Duimstra A, Sinicropi NL, Giacobbe B, Schumacher KR, McCormick AD, Lim HM, Peng DM. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 136Proceeding / Abstract / Poster(282) Characteristics Associated with Elevated Donor-Derived Cell-Free DNA in Pediatric Heart Transplant Recipients without Biopsy Proven Rejection
DOI:10.1016/j.healun.2026.02.290 -
Lytrivi ID, Sleeper LA, Everitt MD, Ahmed H, Albers EL, Alejos JC, Auerbach SR, Carlo WF, D'Addese L, Hsu D, Joong A, Lal AK, Lu M, Lynn M, Magnetta DA, Menteer J, Milligan C, Peng DM, Wen J, Zangwill S, Almond CS, Daly KP. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 138Proceeding / Abstract / Poster(286) Allosensitization and Antibody-Mediated Rejection: It's Not as Simple as DSA. A Report from the TEAMMATE Trial
DOI:10.1016/j.healun.2026.02.294 -
Das BB, Woods R, Puri K, Dazo M, Gajarski R, Peng D, Cabrera A, Schumacher K, Deshpande SR. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 168Proceeding / Abstract / Poster(350) Multimodal Prediction of In-Hospital Mortality After Pediatric Heart Transplantation (PHT): Insights from the Pediatric Cardiac Critical Care Consortium (PC⁴) Registry
DOI:10.1016/j.healun.2026.02.358 -
Najor M, Peng D, McCormick A, Lim H, Hrycaj S, Zamberlan M, Huebschman A, Giacobbe B, Sinicropi N, Mikati HE, Konduri A, Shumacher K, Cusick M. The Journal of Heart and Lung Transplantation, 2026 Apr 18; 45 (5): 330Proceeding / Abstract / Poster(698) To Treat or Not to Treat? Biomarker-Guided Decision Making in a Pediatric Heart Transplant Recipient with Donor-Specific Antibodies
DOI:10.1016/j.healun.2026.02.708 -
El Mikati HK, Najor M, Sinicropi N, Giacobbe B, Cusick M, Lim HM, Peng DM, Schumacher KR, McCormick AD. Transplant Immunology, 2026 Mar 21; 96: 102378Journal ArticleEarly donor-specific antibodies in pediatric patients with Fontan circulation after heart transplant
DOI:10.1016/j.trim.2026.102378 PMID: 41864311
Featured News & Stories